Originator recombinant human follitropin alfa versus recombinant human follitropin alfa biosimilars in Spain: A cost-effectiveness analysis of assisted reproductive technology related to fresh embryo transfers
- DOI
- 10.1016/j.bpobgyn.2022.01.011
- Published
- 2022-12
- Container
- Best Practice & Research Clinical Obstetrics & Gynaecology
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.bpobgyn.2022.01.011,
title = {Originator recombinant human follitropin alfa versus recombinant human follitropin alfa biosimilars in Spain: A cost-effectiveness analysis of assisted reproductive technology related to fresh embryo transfers},
author = {Juan-Enrique Schwarze and Christos Venetis and Silvia Iniesta and Edel Falla and Vasily Lukyanov and Elena de Agustin Calvo and Thomas D´Hooghe and Claudia Roeder and Roberto Matorras},
year = {2022},
journal = {Best Practice \& Research Clinical Obstetrics \& Gynaecology},
doi = {10.1016/j.bpobgyn.2022.01.011},
url = {https://doi.org/10.1016/j.bpobgyn.2022.01.011}
}RIS
TY - JOUR TI - Originator recombinant human follitropin alfa versus recombinant human follitropin alfa biosimilars in Spain: A cost-effectiveness analysis of assisted reproductive technology related to fresh embryo transfers AU - Juan-Enrique Schwarze AU - Christos Venetis AU - Silvia Iniesta AU - Edel Falla AU - Vasily Lukyanov AU - Elena de Agustin Calvo AU - Thomas D´Hooghe AU - Claudia Roeder AU - Roberto Matorras PY - 2022 JO - Best Practice & Research Clinical Obstetrics & Gynaecology DO - 10.1016/j.bpobgyn.2022.01.011 UR - https://doi.org/10.1016/j.bpobgyn.2022.01.011 ER -
APA
Schwarze, J., Venetis, C., Iniesta, S., Falla, E., Lukyanov, V., Calvo, E. D. A., D´Hooghe, T., Roeder, C., & Matorras, R. (2022). Originator recombinant human follitropin alfa versus recombinant human follitropin alfa biosimilars in Spain: A cost-effectiveness analysis of assisted reproductive technology related to fresh embryo transfers. Best Practice & Research Clinical Obstetrics & Gynaecology. https://doi.org/10.1016/j.bpobgyn.2022.01.011
Source records
- crossref · retrieved 2026-09-27T05:59:58.940Z